CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics
CTMX Price/Volume Stats
| Current price | $0.87 | 52-week high | $5.85 |
| Prev. close | $0.89 | 52-week low | $0.83 |
| Day low | $0.85 | Volume | 435,500 |
| Day high | $0.92 | Avg. volume | 2,511,487 |
| 50-day MA | $1.10 | Dividend yield | N/A |
| 200-day MA | $1.59 | Market Cap | 68.09M |
CTMX Stock Price Chart Interactive Chart >
CytomX Therapeutics, Inc. (CTMX) Company Bio
CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.
CTMX Price Returns
| 1-mo | -20.91% |
| 3-mo | -28.10% |
| 6-mo | -50.29% |
| 1-year | -32.56% |
| 3-year | -88.10% |
| 5-year | -85.10% |
| YTD | -43.87% |
| 2023 | -3.13% |
| 2022 | -63.05% |
| 2021 | -33.89% |
| 2020 | -21.18% |
| 2019 | -44.97% |
Continue Researching CTMX
Want to do more research on CytomX Therapeutics Inc's stock and its price? Try the links below:CytomX Therapeutics Inc (CTMX) Stock Price | Nasdaq
CytomX Therapeutics Inc (CTMX) Stock Quote, History and News - Yahoo Finance
CytomX Therapeutics Inc (CTMX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...